Kiniksa Pharmaceuticals/$KNSA
About Kiniksa Pharmaceuticals
Ticker
Industry
Employees
KNSA Metrics
$1.3B
-
-$0.13
0.32
-
Price and volume
Market cap
$1.3B
Beta
0.32
52-week high
$27.92
52-week low
$16.56
Average daily volume
374K
Financial strength
Current ratio
3.244
Quick ratio
2.592
Long term debt to equity
1.96
Total debt to equity
2.424
Management effectiveness
Return on assets (TTM)
-3.16%
Return on equity (TTM)
-2.15%
Valuation
Price to revenue (TTM)
3.387
Price to book
3.03
Price to tangible book (TTM)
3.15
Price to free cash flow (TTM)
117.163
Growth
Revenue change (TTM)
54.41%
Earnings per share change (TTM)
22.55%
3-year revenue growth (CAGR)
168.70%
3-year earnings per share growth (CAGR)
-63.21%
What the Analysts think about KNSA
Analyst Ratings
KNSA Financial Performance
Income Statement
Q3 24
QoQ growth
$37B
-39.75%
$45B
107.52%
37.65%
6.78%
KNSA Earnings Performance
Earnings per share (EPS)
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
$3.69
$2.85
$2.45
$2.42
-
$3.55
$2.61
$2.05
$2.31
$3.94
3.94%
9.20%
19.51%
4.63%
-
KNSA News
Kiniksa Pharmaceuticals Reports Preliminary 2024 Net Product Revenue and Provides 2025 Net Product Revenue Guidance
Kiniksa Pharmaceuticals to Present at 43rd Annual J.P. Morgan Healthcare Conference
Kiniksa Pharmaceuticals to Present at 7th Annual Evercore ISI HealthCONx Conference
FAQs
What’s the current market cap for Kiniksa Pharmaceuticals stock?
What is the P/E ratio for Kiniksa Pharmaceuticals stock?
Does Kiniksa Pharmaceuticals stock pay dividends?
No, Kiniksa Pharmaceuticals (KNSA) stock does not pay dividends to its shareholders as of January 15, 2025.
When is the next Kiniksa Pharmaceuticals dividend payment date?
Kiniksa Pharmaceuticals (KNSA) stock does not pay dividends to its shareholders.
What is the beta indicator for Kiniksa Pharmaceuticals?
Kiniksa Pharmaceuticals (KNSA) has a beta rating of 0.32. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.